JANUET 50/850 MG TABLETS

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

METFORMIN HYDROCHLORIDE 850 MG; SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG

Disponible desde:

MERCK SHARP & DOHME ISRAEL LTD

Código ATC:

A10BA02

formulario farmacéutico:

TABLETS

Vía de administración:

PER OS

Fabricado por:

MERCK SHARP & DOHME CORP., USA

Grupo terapéutico:

METFORMIN

indicaciones terapéuticas:

Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use:Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet.

Fecha de autorización:

2008-12-01